共 7 条
- [2] Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial[J] . Zhijie Wang,Ying Cheng,Tongtong An,Hongjun Gao,Kai Wang,Qing Zhou,Yanping Hu,Yong Song,Cuimin Ding,Feng Peng,Li Liang,Yi Hu,Cheng Huang,Caicun Zhou,Yuankai Shi,Li Zhang,Xin Ye,Meizhuo Zhang,Shaokun Chuai,Guanshan Zhu,Jin Hu,Yi-long Wu,Jie Wang.The Lancet Respiratory
- [4] Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non–Small Cell Lung Cancer[J] . Rui Wan,Zhijie Wang,J. Jack Lee,Shuhang Wang,Qingqing Li,Fuchou Tang,Jin Wang,Yu Sun,Hua Bai,Di Wang,Jun Zhao,Jianchun Duan,Minglei Zhuo,Tongtong An,Meina Wu,Zhaoli Chen,Zhenlin Yang,Jie Wang.Journal of Thoracic Oncology . 2017 (9)
- [5] Applications of Digital PCR for Clinical Microbiology [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (06) : 1621 - 1628